Correlation Between Vanguard California and Edwards Lifesciences
Can any of the company-specific risk be diversified away by investing in both Vanguard California and Edwards Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard California and Edwards Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanguard California Intermediate Term and Edwards Lifesciences Corp, you can compare the effects of market volatilities on Vanguard California and Edwards Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard California with a short position of Edwards Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard California and Edwards Lifesciences.
Diversification Opportunities for Vanguard California and Edwards Lifesciences
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vanguard and Edwards is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard California Intermedia and Edwards Lifesciences Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edwards Lifesciences Corp and Vanguard California is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard California Intermediate Term are associated (or correlated) with Edwards Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edwards Lifesciences Corp has no effect on the direction of Vanguard California i.e., Vanguard California and Edwards Lifesciences go up and down completely randomly.
Pair Corralation between Vanguard California and Edwards Lifesciences
Assuming the 90 days horizon Vanguard California Intermediate Term is expected to generate 0.12 times more return on investment than Edwards Lifesciences. However, Vanguard California Intermediate Term is 8.42 times less risky than Edwards Lifesciences. It trades about -0.29 of its potential returns per unit of risk. Edwards Lifesciences Corp is currently generating about -0.26 per unit of risk. If you would invest 1,138 in Vanguard California Intermediate Term on January 24, 2024 and sell it today you would lose (10.00) from holding Vanguard California Intermediate Term or give up 0.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vanguard California Intermedia vs. Edwards Lifesciences Corp
Performance |
| Timeline |
| Vanguard California |
| Edwards Lifesciences Corp |
Vanguard California and Edwards Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vanguard California and Edwards Lifesciences
The main advantage of trading using opposite Vanguard California and Edwards Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard California position performs unexpectedly, Edwards Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will offset losses from the drop in Edwards Lifesciences' long position.The idea behind Vanguard California Intermediate Term and Edwards Lifesciences Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Edwards Lifesciences vs. HealthStream | Edwards Lifesciences vs. National Research Corp | Edwards Lifesciences vs. HealthEquity | Edwards Lifesciences vs. Health Catalyst |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |